Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H (2014) 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic cardiomyopathy of the European society of cardiology (ESC). Eur Heart J 35(39):2733–2779. https://doi.org/10.1093/eurheartj/ehu284
Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P (2020) 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation 142(25):e558–e631. https://doi.org/10.1161/CIR.0000000000000937
Maron BJ, Friedman RA, Kligfield P, Levine BD, Viskin S, Chaitman BR, Okin PM, Saul JP, Salberg L, Van Hare GF, Soliman EZ, Chen J, Matherne GP, Bolling SF, Mitten MJ, Caplan A, Balady GJ, Thompson PD (2014) Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12–25 years of age). J Am Coll Cardiol 64(14):1479–1514. https://doi.org/10.1016/j.jacc.2014.05.006
Wexler RK, Elton T, Pleister A, Feldman D (2009) Cardiomyopathy: an overview. Am Fam Physician 79(9):778–84
PubMed PubMed Central Google Scholar
Rowin EJ, Maron BJ, Appelbaum E, Link MS, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron MS (2012) Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol 110(7):1027–1032. https://doi.org/10.1016/j.amjcard.2012.05.035
Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, Cohen D, Dimeff R, Douglas PS, Glover DW, Hutter AM Jr, Krauss MD, Maron MS, Mitten MJ, Roberts WO, Puffer JC, American Heart Association Council on Nutrition, Physical Activity, and Metabolism (2007) Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American heart association council on nutrition, physical activity, and metabolism: endorsed by the American college of cardiology foundation. Circulation 15(12):1643–455. https://doi.org/10.1161/CIRCULATIONAHA.107.181423
Savage DD, Seides SF, Clark CE, Henry WL, Maron BJ, Robinson FC, Epstein SE (1978) Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 58(3 Pt 1):402–408. https://doi.org/10.1161/01.cir.58.3.402
Article CAS PubMed Google Scholar
Dipchand AI, McCrindle BW, Gow RM, Freedom RM, Hamilton RM (1999) Accuracy of surface electrocardiograms for differentiating children with hypertrophic cardiomyopathy from normal children. Am J Cardiol 83(4):628–30. https://doi.org/10.1016/s0002-9149(98)00933-3
Article CAS PubMed Google Scholar
Saarel EV, Granger S, Kaltman JR, Minich LL, Tristani-Firouzi M, Kim JJ, Ash K, Tsao SS, Berul CI, Stephenson EA, Gamboa DG, Trachtenberg F, Fischbach P, Vetter VL, Czosek RJ, Johnson TR, Salerno JC, Cain NB, Pass RH, Zeltser I, Silver ES, Kovach JR, Alexander ME, Pediatric Heart Network Investigators* (2018) Electrocardiograms in healthy North American children in the digital age. Circ Arrhythm Electrophysiol. 7:e005808. https://doi.org/10.1161/CIRCEP.117.005808
Davignon A, Rautaharju P, Boisselle E et al (1980) Normal ECG standards for infants and children. Pediatr Cardiol 1:123–131. https://doi.org/10.1007/BF02083144
Charron P, Dubourg O, Desnos M, Bouhour JB, Isnard R, Hagege A, Carrier L, Bonne G, Tesson F, Richard P, Hainque B, Schwartz K, Komajda M (1998) Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J 19(9):1377–1382. https://doi.org/10.1053/euhj.1998.1049
Article CAS PubMed Google Scholar
McLeod CJ, Ackerman MJ, Nishimura RA, Tajik AJ, Gersh BJ, Ommen SR (2009) Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll Cardiol 54(3):229–233. https://doi.org/10.1016/j.jacc.2009.02.071
Norrish G, Topriceanu C, Qu C, Field E, Walsh H, Ziółkowska L, Olivotto I, Passantino S, Favilli S, Anastasakis A, Vlagkouli V, Weintraub R, King I, Biagini E, Ragni L, Prendiville T, Duignan S, McLeod K, Ilina M, Fernández A, Bökenkamp R, Baban A, Drago F, Kubuš P, Daubeney PEF, Chivers S, Sarquella-Brugada G, Cesar S, Marrone C, Medrano C, Alvarez Garcia-Roves R, Uzun O, Gran F, Castro FJ, Gimeno JR, Barriales-Villa R, Rueda F, Adwani S, Searle J, Bharucha T, Siles A, Usano A, Rasmussen TB, Jones CB, Kubo T, Mogensen J, Reinhardt Z, Cervi E, Elliott PM, Omar RZ, Kaski JP (2021) The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy. Eur J Prev Cardiol. 27:zwab046. https://doi.org/10.1093/eurjpc/zwab046
Ostman-Smith I, Wettrell G, Keeton B, Riesenfeld T, Holmgren D, Ergander U (2005) Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly. Cardiol Young 15(6):632–642. https://doi.org/10.1017/S1047951105001824
Ostman-Smith I, Wisten A, Nylander E, Bratt EL, Granelli Ad, Oulhaj A, Ljungström E (2010) Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy. Eur Heart J. 31(4):439–49. https://doi.org/10.1093/eurheartj/ehp443
Balaji S, DiLorenzo MP, Fish FA, Etheridge SP, Aziz PF, Russell MW, Tisma S, Pflaumer A, Sreeram N, Kubus P, Law IH, Kantoch MJ, Kertesz NJ, Strieper M, Erickson CC, Moore JP, Nakano SJ, Singh HR, Chang P, Cohen M, Fournier A, Ilina MV, Smith RT, Zimmerman F, Horndasch M, Li W, Batra A, Liberman L, Hamilton R, Janson CM, Sanatani S, Zeltser I, McDaniel G, Blaufox AD, Garnreiter JM, Katcoff H, Shah M (2019) Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study. Heart Rhythm 16(10):1462–1467. https://doi.org/10.1016/j.hrthm.2019.04.040
Thompson AJ, Cannon BC, Wackel PL, Horner JM, Ackerman MJ, O’Leary PW, Eidem BW, Johnson JN (2016) Electrocardiographic abnormalities in elite high school athletes: comparison to adolescent hypertrophic cardiomyopathy. Br J Sports Med 50(2):105–110. https://doi.org/10.1136/bjsports-2015-094880
Östman-Smith I (2014) Differential diagnosis between left ventricular hypertrophy and cardiomyopathy in childhood. J Electrocardiol. 47(5):661–8. https://doi.org/10.1016/j.jelectrocard.2014.07.002
Brothers MB, Oster ME, Ehrlich A, Strieper MJ, Mahle WT (2014) Novel electrocardiographic screening criterion for hypertrophic cardiomyopathy in children. Am J Cardiol 113(7):1246–1249. https://doi.org/10.1016/j.amjcard.2013.12.039
Drezner JA, Ackerman MJ, Anderson J, Ashley E, Asplund CA, Baggish AL, Börjesson M, Cannon BC, Corrado D, DiFiori JP, Fischbach P, Froelicher V, Harmon KG, Heidbuchel H, Marek J, Owens DS, Paul S, Pelliccia A, Prutkin JM, Salerno JC, Schmied CM, Sharma S, Stein R, Vetter VL, Wilson MG (2013) Electrocardiographic interpretation in athletes: the “Seattle criteria.” Br J Sports Med 47(3):122–124. https://doi.org/10.1136/bjsports-2012-092067
Czosek RJ, Cnota JF, Knilans TK, Pratt J, Guerrier K, Anderson JB (2014) Relationship between echocardiographic LV mass and ECG based left ventricular voltages in an adolescent population: related or random? Pacing Clin Electrophysiol 37(9):1133–1140. https://doi.org/10.1111/pace.12416
Koga Y, Yamaga A, Hiyamuta K, Ikeda H, Toshima H (2004) Mechanisms of abnormal Q waves in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography. J Cardiovasc Electrophysiol 15(12):1402–1408. https://doi.org/10.1046/j.1540-8167.2004.04314.x
Papavassiliu T, Flüchter S, Haghi D, Süselbeck T, Wolpert C, Dinter D, Kühl H, Borggrefe M (2007) Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with q waves in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 9(3):595–603. https://doi.org/10.1080/10976640600945465
Sharma S, Drezner JA, Baggish A et al (2018) International recommendations for electrocardiographic interpretation in athletes. Eur Heart J 39:1466–1480
Konno T, Shimizu M, Ino H, Yamaguchi M, Terai H, Uchiyama K, Oe K, Mabuchi T, Kaneda T, Mabuchi H (2004) Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis. Eur Heart J 25(3):246–251. https://doi.org/10.1016/j.ehj.2003.10.031
Article CAS PubMed Google Scholar
Bent RE, Wheeler MT, Hadley D, Froelicher V, Ashley E, Perez MV (2015) Computerized Q wave dimensions in athletes and hypertrophic cardiomyopathy patients. J Electrocardiol 48(3):362–7. https://doi.org/10.1016/j.jelectrocard.2015.01.009
Zorzi A, Calore C, Vio R, Pelliccia A, Corrado D (2018) Accuracy of the ECG for differential diagnosis between hypertrophic cardiomyopathy and athlete’s heart: comparison between the European Society of Cardiology (2010) and International (2017) criteria. Br J Sports Med 52(10):667–673. https://doi.org/10.1136/bjsports-2016-097438
Comments (0)